A Phase I/II Study Comparing Regimen Schedules of Gemcitabine and Docetaxel in Japanese Patients with Stage IIIB/IV Non-small Cell Lung Cancer

Objective: Gemcitabine and docetaxel are non-platinum agents with activity in non-small cell lung cancer (NSCLC). This study was conducted to determine and evaluate the recommended regimen of gemcitabine–docetaxel and evaluated its efficacy and safety in chemonaive Japanese NSCLC patients. Methods:...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Japanese journal of clinical oncology 2005-04, Vol.35 (4), p.181-187
Hauptverfasser:	Matsui, Kaoru, Hirashima, Tomonori, Nitta, Takashi, Kobayashi, Masashi, Ogata, Yoshitaka, Furukawa, Mitsugi, Kudoh, Shinzoh, Yoshimura, Naruo, Mukohara, Toru, Yamauchi, Setsuko, Shiraishi, Satoshi, Kamoi, Hiroshi, Negoro, Syunichi, Takeda, Kouji, Nakagawa, Kazuhiko, Takada, Minoru, Yana, Takashi, Fukuoka, Masahiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - pathology Deoxycytidine - administration & dosage Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives docetaxel Drug Administration Schedule Female gemcitabine Hemoglobins - analysis Humans Leukopenia - chemically induced Lung Neoplasms - drug therapy Lung Neoplasms - pathology Male Maximum Tolerated Dose Middle Aged Neoplasm Staging non-small cell lung cancer Taxoids - administration & dosage Taxoids - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!